Arcturus Therapeutics
ARCT
ARCT
170 hedge funds and large institutions have $640M invested in Arcturus Therapeutics in 2024 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 45 increasing their positions, 65 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
30% less capital invested
Capital invested by funds: $919M → $640M (-$279M)
31% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 65
Holders
170
Holding in Top 10
–
Calls
$9.61M
Puts
$4.35M
Top Buyers
1 | +$9.65M | |
2 | +$6.98M | |
3 | +$6.96M | |
4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$6.7M |
5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$5.85M |
Top Sellers
1 | -$15.2M | |
2 | -$10.6M | |
3 | -$7.1M | |
4 |
TLP
Tri Locum Partners
New York
|
-$4.69M |
5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$4.52M |